Diabetes mellitus, type 2 Trials in Smithtown, United States
Conditions / Diabetes mellitus, type 2 / Smithtown, United States
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results | COMPLETED | PHASE3 |
| NCT01664247 | The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification | COMPLETED | PHASE3 |
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT01131676 | BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). | COMPLETED | PHASE3 |
| NCT03086330 | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01243424 | CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02030600 | A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT02451137 | A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM) | COMPLETED | PHASE4 |
| NCT01045707 | Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01076647 | Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |